PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsAmenorrhea
MeSH D000568 - amenorrhea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008599:Menstruation disturbances
16 Companies
3 Drugs
$
Success rate
D000568: 
Amenorrhea
43 Companies
11 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMedroxyprogesterone Medroxyprogesterone  2004-10-27   
Ethinyl estradiol, Norelgestromin Onsura  2021-08-25   
Estradiol, Norgestimate Prefest  1999-10-22   
Progesterone Progesterone  2012-02-29   
Novast LaboratoriesEthinyl estradiol, Norgestimate Mono-linyah  2012-05-23   
Ethinyl estradiol, Norgestimate Tri-linyah  2012-05-30   
Ethinyl estradiol, Norgestimate Tri-lo-linyah  2022-09-02   
Glenmark PharmaceuticalsEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2011-06-17   
MylanEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2016-01-27   
Ethinyl estradiol, Norelgestromin Xulane  2014-04-16   
XiromedMedroxyprogesterone Medroxyprogesterone  2018-10-12   
Ethinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2016-01-27   
Ethinyl estradiol, Norgestimate Estarylla  2013-01-30   
Progesterone Progesterone  2017-10-20   
Ethinyl estradiol, Norgestimate Tri-estarylla  2013-01-30   
Ethinyl estradiol, Norgestimate Tri-lo-estarylla  2015-06-29   
Johnson & JohnsonEthinyl estradiol, Norgestimate Ortho Cyclen  1989-12-29   
Ethinyl estradiol, Norelgestromin Ortho Evra  2001-11-20   
Ethinyl estradiol, Norgestimate Ortho Tri-cyclen  1992-07-03   
Ethinyl estradiol, Norgestimate Ortho Tri-cyclen Lo  2002-08-22   
CiplaMedroxyprogesterone Medroxyprogesterone  2019-01-25   
Lupin ResearchEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2012-06-25   
SandozMedroxyprogesterone Medroxyprogesterone  2009-05-20   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
43%
3/7
Phase 3
70%
7/10
Approved: 7Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Estradiol,
Estradiol benzoate,
Estradiol valerate,
Ethinyl estradiol,
Medroxyprogesterone,
Medroxyprogesterone acetate,
Norgestimate,
Progesterone
Mylan
Bromocriptine,
Ethinyl estradiol,
Norelgestromin,
Norgestimate
Johnson & Johnson
Ethinyl estradiol,
Norelgestromin,
Norgestimate
Sandoz
Bromocriptine
Allergan
Ethinyl estradiol,
Norgestimate,
Progesterone
Pfizer
Medroxyprogesterone,
Medroxyprogesterone acetate
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use